Breakpoints

Un podcast de Society of Infectious Diseases Pharmacists - Les vendredis

124 Épisodes

#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals
Publié: 23/09/2022
#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults
Publié: 16/09/2022
#62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs
Publié: 26/08/2022
#61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring
Publié: 19/08/2022
#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID
Publié: 22/07/2022
#59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils
Publié: 15/07/2022
#58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines
Publié: 24/06/2022
#57 – Dosing Consult: Ceftriaxone
Publié: 27/05/2022
#56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives
Publié: 15/04/2022
#55 – One World: Global Perspectives in Antimicrobial Stewardship
Publié: 25/03/2022
#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies
Publié: 18/03/2022
#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management
Publié: 18/02/2022
#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas
Publié: 28/01/2022
#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas
Publié: 21/01/2022
#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP
Publié: 17/12/2021
#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships
Publié: 03/12/2021
#48 – Aligning Goals: Antibiotics in End of Life Care
Publié: 19/11/2021
#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2
Publié: 29/10/2021
#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1
Publié: 22/10/2021
#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials
Publié: 24/09/2021

4 / 7

The SIDP Podcast

Visit the podcast's native language site

124 Épisodes

#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

#62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs

#61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

#59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

#58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

#57 – Dosing Consult: Ceftriaxone

#56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

#55 – One World: Global Perspectives in Antimicrobial Stewardship

#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

#48 – Aligning Goals: Antibiotics in End of Life Care

#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials